{
"id":"mk19_bb_id_s15",
"subspecialtyId":"id",
"title":"Tuberculosis",
"jsonContent":{
"type":"section",
"id":"mk19_bb_id_s15",
"title":{
"__html":"Tuberculosis"
},
"titleNode":{
"type":"section-title",
"hlId":"432448",
"children":[
"Tuberculosis"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_id_s15_1",
"title":{
"__html":"Screening"
},
"titleNode":{
"type":"section-title",
"hlId":"db7551",
"children":[
"Screening"
]
},
"children":[
{
"type":"p",
"hlId":"ad52a2",
"children":[
"The ",
{
"type":"abbreviation",
"title":"interferon-γ release assay",
"children":[
"IGRA"
]
},
" is the initial screening study for latent ",
{
"type":"abbreviation",
"title":"tuberculosis",
"children":[
"TB"
]
},
" infection. A ",
{
"type":"abbreviation",
"title":"tuberculin skin testing",
"children":[
"TST"
]
},
" is the alternative test if IGRA is not feasible or available."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"f71207",
"children":[
"Interpret a positive TST in a patient with a history of bacillus Calmette-Guérin vaccination the same as in a person without a history of this vaccination."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_id_s15_2",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"c98d48",
"children":[
" ",
{
"type":"alert",
"children":[
"Know the different TST threshold measurements for TB infection."
]
},
" "
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_id_s15_inline_t1"
],
"forceOpen":true
},
{
"type":"p",
"hlId":"1156e1",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Latent TB infection"
]
},
" is defined by a positive TST or IGRA in the absence of any systemic manifestation of active infection and a normal chest x-ray."
]
},
{
"type":"p",
"hlId":"807eaf",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Pulmonary TB"
]
},
" accounts for 70% of active disease cases and is characterized by constitutional or pulmonary signs or symptoms that are often insidious and may include:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"0a14b7",
"children":[
"cough >3 weeks, chest pain, and hemoptysis"
]
},
" ",
{
"type":"list-item",
"hlId":"baf810",
"children":[
"fever, chills, and night sweats"
]
},
" ",
{
"type":"list-item",
"hlId":"e4a22a",
"children":[
"weight loss"
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_id_s15_3",
"title":{
"__html":"Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"fa6a5a",
"children":[
"Testing"
]
},
"children":[
{
"type":"p",
"hlId":"0d9e1b",
"children":[
"Obtain chest x-ray and acid-fast bacilli smears and cultures on three sputum specimens in patients with suspected active TB. Sputum or tissue culture is the gold standard for diagnosis, but results may be delayed for weeks. Stains for acid-fast bacilli are rapid but neither sensitive nor specific."
]
},
{
"type":"p",
"hlId":"4039a7",
"children":[
" ",
{
"type":"alert",
"children":[
"Obtain ",
{
"type":"abbreviation",
"title":"nucleic acid amplification testing",
"children":[
"NAAT"
]
},
" of sputum when acid-fast bacilli smear is positive to exclude nontuberculous mycobacteria or to confirm ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Mycobacterium tuberculosis"
]
},
" in patients with high likelihood of disease but negative sputum smears."
]
},
" "
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"9a878e",
"children":[
"A negative NAAT cannot exclude pulmonary TB."
]
},
" ",
{
"type":"list-item",
"hlId":"44e027",
"children":[
"Obtain cultures even if NAAT is positive to determine drug susceptibility."
]
},
" "
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_bb_id_s15_inline_t2"
],
"forceOpen":true
},
{
"type":"p",
"hlId":"57ff83",
"children":[
"CT scans may identify abnormalities not yet visible on chest x-ray."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_bb_id_f07"
],
"forceOpen":true
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_bb_id_f08"
],
"forceOpen":true
},
{
"type":"p",
"hlId":"ed97c3",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"For suspected pleural TB"
]
},
", perform thoracentesis for analysis and culture (positive in only 50% of cases). If negative, perform pleural biopsy. Pleural fluid adenosine deaminase levels are helpful in the evaluation of suspected pleural TB in patients with a negative culture and pleural biopsy."
]
},
{
"type":"p",
"hlId":"a0ab7c",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"TB meningitis"
]
},
" is associated with ",
{
"type":"abbreviation",
"title":"cerebrospinal fluid",
"children":[
"CSF"
]
},
" showing lymphocytic pleocytosis with elevated protein and decreased glucose levels. NAAT of the CSF is highly specific."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"ed623b",
"children":[
"In persons not already known to be HIV positive, test for HIV infection."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_id_s15_4",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"761a09",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"For latent TB:"
]
},
" "
]
},
{
"type":"p",
"hlId":"85361e",
"children":[
"For patients without HIV, select any of the following:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"9b7058",
"children":[
"3 months of isoniazid plus rifapentine given once weekly"
]
},
" ",
{
"type":"list-item",
"hlId":"4c8022",
"children":[
"3 months of isoniazid plus rifampin given daily"
]
},
" ",
{
"type":"list-item",
"hlId":"e55ce0",
"children":[
"4 months of rifampin given daily"
]
},
" "
]
},
{
"type":"p",
"hlId":"3400e7",
"children":[
"In patients with HIV, the first and second regimens listed are acceptable if no drug-drug interactions with HIV medications have been identified."
]
},
{
"type":"p",
"hlId":"1cf418",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"For active TB"
]
},
", the core first-line agents are isoniazid, rifampin, pyrazinamide, and ethambutol. These agents are administered daily for 2 months, and then isoniazid and rifampin are continued daily for either 4 or 7 months."
]
},
{
"type":"p",
"hlId":"ff4d8e",
"children":[
"The three criteria that establishes a patient as no longer infectious:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"03d2e5",
"children":[
"adequate TB treatment >2 weeks"
]
},
" ",
{
"type":"list-item",
"hlId":"82aa02",
"children":[
"improvement of symptoms"
]
},
" ",
{
"type":"list-item",
"hlId":"744c69",
"children":[
"three consecutive negative sputum smears"
]
},
" "
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"98fad3",
"children":[
"If ethambutol is used, visual acuity and color vision testing is recommended."
]
},
" ",
{
"type":"list-item",
"hlId":"6c34dd",
"children":[
"Rifampin is contraindicated or must be used with caution when administered with protease inhibitors and nonnucleoside reverse transcriptase inhibitors; do not administer with saquinavir/ritonavir."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_id_s15_5",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"57af21",
"class":"test",
"children":[
"A 40-year-old asymptomatic female hospital employee has a 10-mm TST reaction following routine screening. The employee was born in India and has lived in the United States for 10 years. She was vaccinated with bacillus Calmette-Guérin as a child. Her chest x-ray is normal."
]
},
{
"type":"p",
"hlId":"2c5462",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For diagnosis, choose latent TB."
]
}
]
}
]
},
"tablesContent":{
"mk19_bb_id_s15_inline_t1":{
"id":"mk19_bb_id_s15_inline_t1",
"number":1,
"bookId":"id",
"title":{
"__html":"Study Table: Interpretation of Tuberculin Skin Test Results"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"6c1ea2",
"children":[
"Study Table: Interpretation of Tuberculin Skin Test Results"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"2a383e",
"class":"col hd l",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Criteria for Tuberculin Positivity by Risk Group"
]
},
" "
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f40e44",
"class":"col hd l",
"children":[
"≥5 mm Induration"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6c3dca",
"class":"col hd l",
"children":[
"≥10 mm Induration"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3e36a9",
"class":"col hd l",
"children":[
"≥15 mm Induration"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"67da67",
"class":"cell txt l",
"children":[
"Persons who are HIV positive"
]
},
" ",
{
"type":"p",
"hlId":"48fc28",
"class":"cell txt l",
"children":[
"Recent contacts of persons with active TB"
]
},
" ",
{
"type":"p",
"hlId":"94bad4",
"class":"cell txt l",
"children":[
"Persons with fibrotic changes on chest x-ray consistent with old TB"
]
},
" ",
{
"type":"p",
"hlId":"fbb5f5",
"class":"cell txt l",
"children":[
"Patients with organ transplants and other immunosuppressive conditions (receiving the equivalent of ≥15 mg/d of prednisone for >4 weeks)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b0d721",
"class":"cell txt l",
"children":[
"Recent (<5 y) arrivals from high-prevalence countries"
]
},
" ",
{
"type":"p",
"hlId":"e5355b",
"class":"cell txt l",
"children":[
"Persons who inject drugs"
]
},
" ",
{
"type":"p",
"hlId":"e1a146",
"class":"cell txt l",
"children":[
"Residents or employees of high-risk congregate settings: prisons and jails, nursing homes and other long-term facilities for older adults, hospitals and other health care facilities, residential facilities for patients with AIDS, homeless shelters"
]
},
" ",
{
"type":"p",
"hlId":"11da5f",
"class":"cell txt l",
"children":[
"Mycobacteriology laboratory personnel; persons with clinical conditions that put them at high risk for active disease; children aged <4 years or those exposed to adults in high-risk categories"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c6383a",
"class":"cell txt l",
"children":[
"All others with no risk factors for TB"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_bb_id_s15_inline_t2":{
"id":"mk19_bb_id_s15_inline_t2",
"number":2,
"bookId":"id",
"title":{
"__html":"Study Table: Chest X-ray Patterns for Pulmonary TB"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"354ade",
"children":[
"Study Table: Chest X-ray Patterns for Pulmonary TB"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"48d8d6",
"class":"col hd l",
"children":[
"Syndrome"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"573911",
"class":"col hd l",
"children":[
"Pattern"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8fba5b",
"class":"cell txt l",
"children":[
"Reactivation TB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"95847c",
"class":"cell txt l",
"children":[
"Infiltrates in the apical-posterior segments of the upper lung and superior segments of the lower lobe"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"42c42e",
"class":"cell txt l",
"children":[
"Primary progressive TB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"51996c",
"class":"cell txt l",
"children":[
"Hilar lymphadenopathy or infiltrates in any part of the lung"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c6f578",
"class":"cell txt l",
"children":[
"Cavitary TB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d42800",
"class":"cell txt l",
"children":[
"Cavities ",
{
"type":"alert",
"children":[
"without air-fluid levels"
]
},
"; may be associated with either primary progressive or reactivation TB"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"52251d",
"class":"cell txt l",
"children":[
"Immunocompromised patients"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"68de7a",
"class":"cell txt l",
"children":[
"Typical or absent radiologic findings are common"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c1655a",
"class":"cell txt l",
"children":[
"Miliary TB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ff6b21",
"class":"cell txt l",
"children":[
"Characteristic “millet seed” appearance (uniform reticulonodular infiltrate)"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}